Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 4

1.

Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: a randomized phase III trial of the European Osteosarcoma Intergroup.

Lewis IJ, Nooij MA, Whelan J, Sydes MR, Grimer R, Hogendoorn PC, Memon MA, Weeden S, Uscinska BM, van Glabbeke M, Kirkpatrick A, Hauben EI, Craft AW, Taminiau AH; MRC BO06 and EORTC 80931 collaborators; European Osteosarcoma Intergroup.

J Natl Cancer Inst. 2007 Jan 17;99(2):112-28.

PMID:
17227995
2.

Analysis of chemotherapy dosage and dosage intensity and survival outcomes of high-grade osteosarcoma patients younger than 40 years.

Sun L, Li Y, Li H, Zhang J, Li B, Ye Z.

Clin Ther. 2014 Apr 1;36(4):567-78. doi: 10.1016/j.clinthera.2014.02.018. Epub 2014 Mar 14. Review.

PMID:
24636527
3.

Six versus fewer planned cycles of first-line platinum-based chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual patient data.

Rossi A, Chiodini P, Sun JM, O'Brien ME, von Plessen C, Barata F, Park K, Popat S, Bergman B, Parente B, Gallo C, Gridelli C, Perrone F, Di Maio M.

Lancet Oncol. 2014 Oct;15(11):1254-62. doi: 10.1016/S1470-2045(14)70402-4. Epub 2014 Sep 14. Review.

PMID:
25232001
4.

International collaboration is feasible in trials for rare conditions: the EURAMOS experience.

Marina N, Bielack S, Whelan J, Smeland S, Krailo M, Sydes MR, Butterfass-Bahloul T, Calaminus G, Bernstein M.

Cancer Treat Res. 2009;152:339-53. doi: 10.1007/978-1-4419-0284-9_18. Review.

PMID:
20213400

Supplemental Content

Support Center